Manfred Kraus
Vice-President, Head of R&D Therapeutics Kernal Biologics
Seminars
Advancing Onco-Selective mRNA Therapeutics with Kernal’s KR-335 Program to Kill Tumor Cells
3:15 pm
- 3:45 pm
Vice-President, Head of R&D Therapeutics Kernal Biologics